Clinical Trials

Study Title:
First in Human, Phase 1/1b, Open label, Multicenter Study of Bifunctional EGFR/TGF ß Fusion Protein BCA101 Monotherapy and in Combination Therapy in Patients with EGFR Driven Advanced Solid Tumors

For more information about the trial above please contact the study team:

Medical University of South Carolina
Principal Investigator, Kaczmar, John, at kaczmar@musc.edu, or please call +1 843-792-6691.
Study Coordinator, Boggan, Holly, at bogganhl@musc.edu, or please call +1 843-792-8068.

Trial opened at the following institutions: Medical University of South Carolina